Tokio Marine Asset Management Co. Ltd. lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 21.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,417 shares of the medical research company’s stock after selling 938 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Agilent Technologies were worth $219,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. HighTower Advisors LLC lifted its stake in shares of Agilent Technologies by 37.4% during the 1st quarter. HighTower Advisors LLC now owns 12,875 shares of the medical research company’s stock valued at $678,000 after buying an additional 3,504 shares in the last quarter. New England Research & Management Inc. lifted its stake in shares of Agilent Technologies by 25.2% during the 2nd quarter. New England Research & Management Inc. now owns 6,700 shares of the medical research company’s stock valued at $397,000 after buying an additional 1,350 shares in the last quarter. Bank of Montreal Can lifted its stake in shares of Agilent Technologies by 27.9% during the 2nd quarter. Bank of Montreal Can now owns 227,044 shares of the medical research company’s stock valued at $13,467,000 after buying an additional 49,583 shares in the last quarter. Pennsylvania Trust Co purchased a new position in shares of Agilent Technologies during the 2nd quarter valued at $212,000. Finally, NN Investment Partners Holdings N.V. lifted its stake in shares of Agilent Technologies by 1,352.4% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 181,551 shares of the medical research company’s stock valued at $10,767,000 after buying an additional 169,051 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: This report was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.watchlistnews.com/tokio-marine-asset-management-co-ltd-has-219000-stake-in-agilent-technologies-inc-a/1682879.html.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 16,492 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $65.33, for a total value of $1,077,422.36. Following the completion of the sale, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Didier Hirsch sold 15,555 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the completion of the sale, the chief financial officer now directly owns 178,557 shares of the company’s stock, valued at $11,784,762. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 165,720 shares of company stock worth $10,488,739.

A number of research firms recently weighed in on A. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Monday, October 30th. BidaskClub cut shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. Janney Montgomery Scott lifted their target price on shares of Agilent Technologies from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, August 16th. J P Morgan Chase & Co restated an “overweight” rating and set a $70.00 target price on shares of Agilent Technologies in a research note on Wednesday, August 16th. Finally, Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $68.00 target price on shares of Agilent Technologies in a research note on Tuesday, September 26th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $65.78.

Shares of Agilent Technologies, Inc. (NYSE A) opened at $68.37 on Monday. Agilent Technologies, Inc. has a fifty-two week low of $42.92 and a fifty-two week high of $68.67. The company has a quick ratio of 2.76, a current ratio of 3.22 and a debt-to-equity ratio of 0.39. The firm has a market cap of $22,003.38, a PE ratio of 29.86, a PEG ratio of 2.68 and a beta of 1.27.

Agilent Technologies (NYSE:A) last posted its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the previous year, the firm posted $0.49 EPS. The business’s quarterly revenue was up 6.7% on a year-over-year basis. research analysts anticipate that Agilent Technologies, Inc. will post 2.32 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd were issued a $0.132 dividend. The ex-dividend date was Monday, October 2nd. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.77%. Agilent Technologies’s dividend payout ratio (DPR) is presently 27.32%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.